ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Arthroplasty"

  • Abstract Number: 2052 • 2016 ACR/ARHP Annual Meeting

    Preoperative Timing of Infliximab and Risk of Post-Operative Infection in a Medicare Cohort

    Michael D. George1, Joshua F. Baker1, Jesse Yenchih Hsu2, Qufei Wu3, Fenglong Xie4, Lang Chen4, Huifeng Yun5 and Jeffrey Curtis6, 1Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Biostatistics, University of Pennsylvania, Philadelphia, PA, 3Biostatistics and Analysis Center, University of Pennsylvania, Philadelphia, PA, 4Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 5Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, AL, 6Division Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Patients taking biologic DMARDs often undergo elective surgery, but data to guide if and when to hold biologics before surgery is limited. This study…
  • Abstract Number: 2331 • 2016 ACR/ARHP Annual Meeting

    Trends in Joint Replacement Surgery in Patients with Rheumatoid Arthritis

    Jasvinder A. Singh1, Bradley Young2, Shawna Watson3, jorge perez2, Gerald McGwin2 and Brent Ponce2, 1Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3university of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: The purpose of this study was to analyze time-trends in various types of total joint arthroplasty (TJA) and assess if the proportion of the…
  • Abstract Number: 1281 • 2015 ACR/ARHP Annual Meeting

    Reduction in Rural-Urban Disparity in Discharge Disposition to Home after Total Knee Arthroplasty in the U.S

    Jasvinder A. Singh and Rekha Ramachandaran, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Rural-urban disparities in outcomes after total joint arthroplasty are of great interest, given the differences in health care access and social support between those…
  • Abstract Number: 1417 • 2015 ACR/ARHP Annual Meeting

    Rural Residence Does Not Impact Total Ankle Arthroplasty Utilization and Outcomes

    Jasvinder A. Singh and Rekha Ramachandaran, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose:   It is not known whether there are rural-urban disparities in Total Ankle Arthroplasty (TAA), given that TAA is a relatively new procedure and…
  • Abstract Number: 1418 • 2015 ACR/ARHP Annual Meeting

    The Importance of Comorbidity in Understanding the 6-Month Trajectories of Pain and Function after Total Hip Arthroplasty

    C. Allyson Jones1, Gian S. Jhangri2, Lauren A. Beaupre1 and Maria E. Suarez-Almazor3, 1Physical Therapy, University of Alberta, Edmonton, AB, Canada, 2School of Public Health, University of Alberta, Edmonton, AB, Canada, 3General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX

    Background/Purpose: Osteoarthritis (OA) is chronic condition associated with a number of other comorbidities which may affect the 6 month pattern of recovery of total hip…
  • Abstract Number: 1490 • 2015 ACR/ARHP Annual Meeting

    Can Patients Forget Their Artificial Joint after Arthroplasty?

    Gizem Irem KINIKLI1, Hande GUNEY2, Sercan ONAL2, Ceyda SARIAL2, Dilara DONDER2, Inci YUKSEL2, Omur CAGLAR3 and Gulay KINIKLI4, 1Department of Physiotherapy and Rehabilitation, Hacettepe University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Ankara, Turkey, 2Department of Physiotherapy and Rehabilitation, Hacettepe University, Faculty of Health Sciences, Ankara, Turkey, 3Department of Orthopedics and Traumatology, Hacettepe University, Faculty of Medicine, Ankara, Turkey, 4Department of Rheumatology, Ankara University, Faculty of Medicine, Ankara, Turkey

    Background/Purpose: Knee and hip osteoarthritis (OA) are the clinical outcome of a functional and structural failure resulting with pain and physical dysfunction. Total joint arthroplasty…
  • Abstract Number: 2114 • 2015 ACR/ARHP Annual Meeting

    Higher Total Knee Arthroplasty Revision Rates in Black Americans: A Systematic Literature Review and Meta-Analysis

    Anne R. Bass1, Kelly McHugh1, Kara Fields2,3, Rie Smethurst4, Michael Parks5 and Susan M. Goodman1, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Medicine/Rheumatology, Hospital for Special Surgery, New York, NY, 3Biostatistics, Hospital for Special Surgery, New York, NY, 4Education - Academic Training, Hospital for Special Surgery, New York, NY, 5Orthopedics, Hospital for Special Surgery, New York, NY

    Background/Purpose: Utilization of total knee arthroplasty (TKA) is lower among blacks than whites in the United States (U.S.), which may be due to blacks' perception…
  • Abstract Number: 2252 • 2015 ACR/ARHP Annual Meeting

    Declining Post-Arthroplasty Mortality after Total Knee Arthroplasty in the U.S.: A Time-Trends Study

    Jasvinder A. Singh and Rekha Ramachandaran, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Total Knee Arthroplasty (TKA) is mostly an elective procedure that is effective in improving pain, function and quality of life in patients with end-stage…
  • Abstract Number: 2253 • 2015 ACR/ARHP Annual Meeting

    Racial Disparities in Total Shoulder Arthroplasty Utilization and Outcomes Are Persisting

    Jasvinder A. Singh and Rekha Ramachandaran, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: A recent study that used the 1993-2007 U.S. Nationwide Inpatient Sample (NIS) reported that Blacks had lower overall Total Shoulder Arthroplasty (TSA) utilization rates…
  • Abstract Number: 2970 • 2014 ACR/ARHP Annual Meeting

    Psoriatic Arthritis is Associated with Heterotopic Ossification after Total Hip Arthroplasty

    Mario Cedillo1, Arielle Fein2, Susan M. Goodman3, Rebecca Zhu4, Mark P. Figgie5, Michael Alexiades6, Jayme C. Burket7 and Lisa A. Mandl3, 1Weill Cornell Medical College, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Rheumatology, Hospital for Special Surgery, New York, NY, 4Clinical Research, Hospital for Special Surgery, New York, NY, 5Orthopedics, Hospital for Special Surgery, New York, NY, 6Orthopaedics, Hospital for Special Surgery, New York, NY, 7Healthcare Research Institute, Hospital for Special Surgery, New York, NY

    Background/Purpose:  Heterotopic ossification (HO), the pathologic deposition of ectopic bone in soft tissues, is a feared complication of total hip arthroplasty (THA). HO is strongly…
  • Abstract Number: 2369 • 2014 ACR/ARHP Annual Meeting

    Management of Perioperative Tumor Necrosis -á Inhibitors in Rheumatoid Arthritis Undergoing Arthroplasty: A Systematic Review and Meta-Analysis

    Susan M. Goodman1, Indu Menon2, Rie Smethurst3, Paul Christos4 and Vivian P. Bykerk1, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Rheumatology, Hospital for Special Surgery, NY, NY, 3Education - Academic Training, Hospital for Special Surgery, NY, NY, 4Healthcare Policy and Research, Weill Cornell Medical College, NY, NY

    Background/Purpose: Tumor Necrosis Factor α inhibitors (TNFi) are widely used in patients with RA (Rheumatoid Arthritis) undergoing orthopedic surgery, yet its optimal perioperative management is…
  • Abstract Number: 2370 • 2014 ACR/ARHP Annual Meeting

    Management of Perioperative Tumor Necrosis Factor α Inhibitors in Rheumatoid Arthritis Undergoing Arthroplasty: A Systematic Review and Meta-Analysis

    Susan M. Goodman1, Indu Menon2, Rie Smethurst3, Paul Christos4 and Vivian P. Bykerk1, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Rheumatology, Hospital for Special Surgery, NY, NY, 3Education - Academic Training, Hospital for Special Surgery, NY, NY, 4Healthcare Policy and Research, Weill Cornell Medical College, NY, NY

    Background/Purpose: Tumor Necrosis Factor α inhibitors (TNFi) are widely used in patients with RA (Rheumatoid Arthritis) undergoing orthopedic surgery, yet its optimal perioperative management is…
  • Abstract Number: 1802 • 2014 ACR/ARHP Annual Meeting

    Are Outcomes after Total Knee Arthroplasty Worsening over Time? a Time-Trends Study of Activity Limitation and Pain Outcomes

    Jasvinder A. Singh1 and David Lewallen2, 1University of Alabama and VA Medical Center, Birmingham, AL, 2Orthopedics, Mayo Clinic college of medicine, Rochester, MN

    Background/Purpose: To examine whether function and pain outcomes of patients undergoing primary total knee arthroplasty (TKA) are changing over time.Methods: The Mayo Clinic Total Joint…
  • Abstract Number: 191 • 2014 ACR/ARHP Annual Meeting

    Utilization and Outcomes Following Total Shoulder Arthroplasty in Elderly and Non-Elderly Patients

    Jasvinder A. Singh1 and Rekha Ramachandaran2, 1University of Alabama and VA Medical Center, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: To assess the age-related differences in total shoulder arthroplasty (TSA) outcomes and utilization and associated time-trends.Methods: Nationwide Inpatient Sample (NIS) from 1998-2010 was used…
  • Abstract Number: 190 • 2014 ACR/ARHP Annual Meeting

    Hospital Volume Predicts Outcomes and Complications after Total Shoulder Arthroplasty

    Jasvinder A. Singh1 and Rekha Ramachandaran2, 1University of Alabama and VA Medical Center, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: To assess the association of hospital procedure volume for total shoulder arthroplasty (TSA) with patient outcomes and complications.Methods: We used the Nationwide Inpatient Sample…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology